Major Pharmaceutical Company Automates Cloud Lifecycle Management

The Challenge

A major US pharmaceutical company, with over $45 billion in revenue, faced challenges in automating their virtual server lifecycle management across a hybrid cloud environment. Repeated failures with various vendors led to delays in crucial project timelines, impacting time-to-market for critical products. The lack of a comprehensive cloud management solution served as a hindrance to the automation of virtual server processes, leading to high provisioning times and inefficiency. This had a direct effect on their ability to bring new medicines to market quickly, a critical factor in the pharmaceutical industry where time is of the essence.

Their IT environment was highly complex, involving multiple teams and layers of human intervention to produce a fully compliant virtual server. The lack of a streamlined, automated process meant that each provisioning task required extensive manual efforts, often resulting in delays that impacted their ability to meet project deadlines. We all know, manual processes are prone to errors, particularly in meeting mandatory compliance requirements during provisioning. Each layer of human intervention increased the risk of mistakes, leading to an inconsistent and sub-standard virtual server environment across the hybrid cloud landscape. Failure to standardize and enforce compliance across the environment also exposed them to potential regulatory risks. Previously engaged with multiple vendors to automate the virtual server provisioning and day-2 processes, unfortunately, each attempt failed. The inability to find a reliable automation solution only exacerbated the challenges, leaving them in a state of operational inefficiency and uncertainty.